COSMOS HEALTH INC. (COSM)

0.23 +4.17% (+0.01)

Over 5Y: -95.4%

2026-08-28
10 20
2021 2022 2023 2024 2025 2026

Financials Quarterly

Q3 '21 — Revenue: 13.6M Q3 '21 — Operating Cash Flow: -3M Q3 '21 — Free Cash Flow: -3.5M Q3 '21 — Net Income: -1.9M Q4 '21 — Revenue: 16.2M Q4 '21 — Operating Cash Flow: -1.5M Q4 '21 — Free Cash Flow: -1.6M Q4 '21 — Net Income: -1.5M Q1 '22 — Revenue: 13.1M Q1 '22 — Operating Cash Flow: -2.3M Q1 '22 — Free Cash Flow: -2.3M Q1 '22 — Net Income: 203.3K Q2 '22 — Revenue: 13.2M Q2 '22 — Operating Cash Flow: -686.4K Q2 '22 — Free Cash Flow: -713.5K Q2 '22 — Net Income: -1.2M Q3 '22 — Revenue: 12M Q3 '22 — Operating Cash Flow: -1.5M Q3 '22 — Free Cash Flow: -1.5M Q3 '22 — Net Income: -2M Q4 '22 — Revenue: 12.1M Q4 '22 — Operating Cash Flow: -10.3M Q4 '22 — Free Cash Flow: -10.4M Q4 '22 — Net Income: -10.8M Q1 '23 — Revenue: 12.3M Q1 '23 — Operating Cash Flow: -6.3M Q1 '23 — Free Cash Flow: -6.4M Q1 '23 — Net Income: -459.9K Q2 '23 — Revenue: 12.4M Q2 '23 — Operating Cash Flow: -5.7M Q2 '23 — Free Cash Flow: -6.9M Q2 '23 — Net Income: -981.5K Q3 '23 — Revenue: 12.8M Q3 '23 — Operating Cash Flow: -4.5M Q3 '23 — Free Cash Flow: -4.5M Q3 '23 — Net Income: -3.3M Q4 '23 — Revenue: 15.8M Q4 '23 — Operating Cash Flow: 951.7K Q4 '23 — Free Cash Flow: 905K Q4 '23 — Net Income: -13.8M Q1 '24 — Revenue: 14.6M Q1 '24 — Operating Cash Flow: -3.4M Q1 '24 — Free Cash Flow: -3.5M Q1 '24 — Net Income: -1.9M Q2 '24 — Revenue: 13.2M Q2 '24 — Operating Cash Flow: -1.2M Q2 '24 — Free Cash Flow: -1.2M Q2 '24 — Net Income: -2.6M Q3 '24 — Revenue: 12.4M Q3 '24 — Operating Cash Flow: 739.8K Q3 '24 — Free Cash Flow: 511K Q3 '24 — Net Income: -8.4M Q4 '24 — Revenue: 14.2M Q4 '24 — Operating Cash Flow: -3.8M Q4 '24 — Free Cash Flow: -3.9M Q4 '24 — Net Income: -3.3M Q1 '25 — Revenue: 13.7M Q1 '25 — Operating Cash Flow: -186.3K Q1 '25 — Free Cash Flow: -198.8K Q1 '25 — Net Income: -818.1K Q2 '25 — Revenue: 14.7M Q2 '25 — Operating Cash Flow: -1.2M Q2 '25 — Free Cash Flow: -1.2M Q2 '25 — Net Income: -2.8M Q3 '25 — Revenue: 17.1M Q3 '25 — Operating Cash Flow: -2.5M Q3 '25 — Free Cash Flow: -2.5M Q3 '25 — Net Income: -5.4M Q4 '25 — Revenue: 19.7M Q4 '25 — Operating Cash Flow: -4.6M Q4 '25 — Free Cash Flow: -4.6M Q4 '25 — Net Income: -10.1M Q1 '26 — Revenue: 17.9M Q1 '26 — Operating Cash Flow: -1.1M Q1 '26 — Free Cash Flow: -1.1M Q1 '26 — Net Income: -2.8M Q2 '26 — Revenue: 19M Q2 '26 — Operating Cash Flow: -1.7M Q2 '26 — Free Cash Flow: -1.8M Q2 '26 — Net Income: -6.1M -7M 0 7M 14M 21M
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

2.2
OE margin -16.5%
Oper. margin -24.9%
ROIC -65.7%
Accruals -23.7%
EBITDA margin -23.0%
FCF margin -13.5%
Gross margin 10.3%
OCF margin -13.3%
Profit margin -33.1%
ROA -39.7%
ROCE -68.9%
ROE -118.0%
OCF / EBIT —

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

3.4
RPO / sales 0.025×
RPO growth —
Segment HHI —

4 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

1.3
ND/EBITDA —
Interest cover -18.1×
Debt / Eq 0.15×
Net debt / Eq 0.066×
Cash / Debt 0.58×
Quick ratio 0.92×
F-score 5.0 pts
Cash runway —
Debt payback —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

1.2
Sales/sh Y/Y -15.4%
Sales Q/Q +28.8%
Shares change +58.2%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.